← Back to directory

Jian Zhu

Researcher Next ID · RN-026176

Researcher · Biochemistry, Genetics and Molecular Biology

Shanxi Medical University

Taiyuan, Latvia

Not currently recruitingFunding unknown
Works count
115
Citation count
2,913
H-index
32
i10-index
60

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
MicroRNA in disease regulation
Hippo pathway signaling and YAP/TAZ
Spondyloarthritis Studies and Treatments
Circular RNAs in diseases
Breast Cancer Treatment Studies

Publications

  • Cross-linkable molecule in spatial dimension boosting water-stable and high-efficiency perovskite solar cells

    Nano Energy · 2021 · 10.1016/j.nanoen.2021.106846

  • Varied thyroid disrupting effects of perfluorooctanoic acid (PFOA) and its novel alternatives hexafluoropropylene-oxide-dimer-acid (GenX) and ammonium 4,8-dioxa-3H-perfluorononanoate (ADONA) in vitro

    Environment International · 2021 · 10.1016/j.envint.2021.106745

  • Regulation of Hippo signaling and triple negative breast cancer progression by an ubiquitin ligase RNF187

    Oncogenesis · 2020 · 10.1038/s41389-020-0220-5

  • SMURF1 facilitates estrogen receptor ɑ signaling in breast cancer cells

    Journal of Experimental & Clinical Cancer Research · 2018 · 10.1186/s13046-018-0672-z

  • MicroRNA-302a/d inhibits the self-renewal capability and cell cycle entry of liver cancer stem cells by targeting the E2F7/AKT axis

    Journal of Experimental & Clinical Cancer Research · 2018 · 10.1186/s13046-018-0927-8

  • SHARPIN stabilizes estrogen receptor α and promotes breast cancer cell proliferation

    Oncotarget · 2017 · 10.18632/oncotarget.20368

  • SOX2 regulates multiple malignant processes of breast cancer development through the SOX2/miR-181a-5p, miR-30e-5p/TUSC3 axis

    Molecular Cancer · 2017 · 10.1186/s12943-017-0632-9

  • MicroRNA-29c-5p suppresses gallbladder carcinoma progression by directly targeting CPEB4 and inhibiting the MAPK pathway

    Cell Death and Differentiation · 2017 · 10.1038/cdd.2016.146

  • Recent advances in activatable fluorescence imaging probes for tumor imaging

    Drug Discovery Today · 2017 · 10.1016/j.drudis.2017.04.006

  • High expression of miR-105-1 positively correlates with clinical prognosis of hepatocellular carcinoma by targeting oncogene NCOA1

    Oncotarget · 2017 · 10.18632/oncotarget.14435

  • Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer

    Journal of Experimental & Clinical Cancer Research · 2016 · 10.1186/s13046-016-0346-7

  • p21-activated kinase group II small compound inhibitor GNE-2861 perturbs estrogen receptor alpha signaling and restores tamoxifen-sensitivity in breast cancer cells

    Oncotarget · 2015 · 10.18632/oncotarget.6081

  • Identification of plasma microRNA profiles for primary resistance to EGFR-TKIs in advanced non-small cell lung cancer (NSCLC) patients with EGFR activating mutation

    Journal of Hematology & Oncology · 2015 · 10.1186/s13045-015-0210-9

  • Magnolol inhibits growth of gallbladder cancer cells through the p53 pathway

    Cancer Science · 2015 · 10.1111/cas.12762

  • AP-1-mediated chromatin looping regulates ZEB2 transcription: new insights into TNFα-induced epithelial-mesenchymal transition in triple-negative breast cancer

    Oncotarget · 2015 · 10.18632/oncotarget.3158

  • The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferation

    Oncogene · 2014 · 10.1038/onc.2013.573

  • Systematic identification of transcriptional and post-transcriptional regulations in human respiratory epithelial cells during influenza A virus infection

    BMC Bioinformatics · 2014 · 10.1186/1471-2105-15-336

  • Efficacy of Neonatal HBV Vaccination on Liver Cancer and Other Liver Diseases over 30-Year Follow-up of the Qidong Hepatitis B Intervention Study: A Cluster Randomized Controlled Trial

    PLoS Medicine · 2014 · 10.1371/journal.pmed.1001774

  • Enhancement Patterns and Parameters of Breast Cancers at Contrast-enhanced US: Correlation with Prognostic Factors

    Radiology · 2012 · 10.1148/radiol.11110789

  • New selenium‐based iniferter agent for living free radical polymerization of styrene under UV irradiation

    Journal of Polymer Science Part A Polymer Chemistry · 2012 · 10.1002/pola.25994

  • A potentially functional polymorphism in the promoter region of miR‐34b/c is associated with an increased risk for primary hepatocellular carcinoma

    International Journal of Cancer · 2010 · 10.1002/ijc.25342

  • Idiopathic retroperitoneal fibrosis (RPF): clinical features of 61 cases and literature review

    Clinical Rheumatology · 2010 · 10.1007/s10067-010-1580-6

  • CTLA-4 gene polymorphism +49 A/G contributes to genetic susceptibility to two infection-related cancers—hepatocellular carcinoma and cervical cancer

    Human Immunology · 2010 · 10.1016/j.humimm.2010.05.023

  • Trends in the incidence of cancer in Qidong, China, 1978–2002

    International Journal of Cancer · 2006 · 10.1002/ijc.21952

  • Histone deacetylase 1 represses the small GTPase RhoB expression in human nonsmall lung carcinoma cell line

    Oncogene · 2003 · 10.1038/sj.onc.1206653

Current projects

    No projects listed.